Drug: Midazolam: chronic pain clinical trials
Registry records that list "Drug: Midazolam" as an intervention. Being studied does not mean an intervention works or is approved.
0
Trials with Canadian sites
0
Recruiting in Canada
5
Registry records in total
Trials in Canada
No trial with a Canadian site lists this intervention in this snapshot.
Trials worldwide (outside Canada)
5 trials, 0 recruiting or not yet recruiting. Recruiting first.
| Phase | Countries | ||||
|---|---|---|---|---|---|
| Ketamine and Midazolam Infusions for CRPS: Feasibility Study NCT05945147 | Withdrawn | Phase 2 | United States | Stanford University | 2099-01-01 |
| Study on the Safety of BAY1817080, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug in Participants With Impaired Liver Function or Normal Liver Function NCT04454424 | Completed | Phase 1 | United States | Bayer | 2020-07-23 |
| Dexmedetomidine Versus Fentanyl Following Pressure Equalization Tube Placement NCT01188551 | Completed | Phase 2, Phase 3 | United States | Nationwide Children's Hospital | 2011-01 |
| Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1940 NCT00689780 | Completed | Phase 1 | Sweden | AstraZeneca | 2008-03 |
| Pilot Study of Spinal Manipulation for Chronic Neck Pain NCT00030004 | Terminated | Phase 1 | United States | National Center for Complementary and Integrative Health (NCCIH) | 2000-05 |
Conditions studied with this intervention
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.